다우존스 지수

실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Context Therapeutics Inc (CNTX)
Context Therapeutics Inc (CNTX) 뉴스

CNTX

Context Therapeutics (CNTX)

Context Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:CNTX

1 2 3 4 5 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/17	05:01	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:CNTX	Context Therapeutics Inc
2024/05/11	05:00	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:CNTX	Context Therapeutics Inc
2024/05/09	05:06	GlobeNewswire Inc.	Context Therapeutics Reports First Quarter 2024 Operating and Financial Results	NASDAQ:CNTX	Context Therapeutics Inc
2024/05/09	05:03	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:CNTX	Context Therapeutics Inc
2024/05/02	20:31	GlobeNewswire Inc.	Context Therapeutics Announces FDA Clearance of IND Application for a Phase 1 Clinical Trial of CTIM-76	NASDAQ:CNTX	Context Therapeutics Inc
2024/05/02	20:30	GlobeNewswire Inc.	Context Therapeutics Announces $100 Million Private Placement	NASDAQ:CNTX	Context Therapeutics Inc
2024/04/01	20:30	GlobeNewswire Inc.	Context Therapeutics Submits IND Application to Evaluate CTIM-76 in Claudin 6-Positive Cancers	NASDAQ:CNTX	Context Therapeutics Inc
2024/03/21	20:43	GlobeNewswire Inc.	Context Therapeutics Reports Full Year 2023 Operating and Financial Results	NASDAQ:CNTX	Context Therapeutics Inc
2024/03/06	21:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CNTX	Context Therapeutics Inc
2024/02/08	06:24	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:CNTX	Context Therapeutics Inc
2023/11/10	06:15	GlobeNewswire Inc.	Context Therapeutics Reports Third Quarter 2023 Operating and Financial Results	NASDAQ:CNTX	Context Therapeutics Inc
2023/11/10	06:04	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:CNTX	Context Therapeutics Inc
2023/10/31	22:04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CNTX	Context Therapeutics Inc
2023/10/31	22:00	GlobeNewswire Inc.	Context Therapeutics Announces Preclinical Data Demonstrating Differentiated and Active Profile of its Claudin 6-Targeted Bispecific Antibody CTIM-76	NASDAQ:CNTX	Context Therapeutics Inc
2023/09/27	22:00	GlobeNewswire Inc.	Context Therapeutics Announces Acceptance of Abstract to be Presented at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting	NASDAQ:CNTX	Context Therapeutics Inc
2023/08/10	05:10	GlobeNewswire Inc.	Context Therapeutics Reports Second Quarter 2023 Operating and Financial Results	NASDAQ:CNTX	Context Therapeutics Inc
2023/08/10	05:04	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:CNTX	Context Therapeutics Inc
2023/08/07	21:11	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CNTX	Context Therapeutics Inc
2023/08/01	20:30	GlobeNewswire Inc.	Context Therapeutics to Participate in Two August 2023 Investor Conferences	NASDAQ:CNTX	Context Therapeutics Inc
2023/06/20	21:36	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CNTX	Context Therapeutics Inc
2023/06/01	05:53	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CNTX	Context Therapeutics Inc
2023/05/11	05:39	GlobeNewswire Inc.	Context Therapeutics Reports First Quarter 2023 Operating and Financial Results	NASDAQ:CNTX	Context Therapeutics Inc
2023/04/03	20:30	GlobeNewswire Inc.	Context Therapeutics to Participate in Two April 2023 Investor Conferences	NASDAQ:CNTX	Context Therapeutics Inc
2023/03/28	05:04	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	NASDAQ:CNTX	Context Therapeutics Inc
2023/03/23	06:10	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CNTX	Context Therapeutics Inc
2023/03/23	06:08	GlobeNewswire Inc.	Context Therapeutics Reports Full Year 2022 Financial Results and Recent Pipeline Updates	NASDAQ:CNTX	Context Therapeutics Inc
2023/03/15	20:30	GlobeNewswire Inc.	Context Therapeutics Announces Acceptance of Abstract to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2023	NASDAQ:CNTX	Context Therapeutics Inc
2023/02/15	07:26	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CNTX	Context Therapeutics Inc
2023/02/15	07:26	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CNTX	Context Therapeutics Inc
2023/02/15	07:25	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CNTX	Context Therapeutics Inc

검색 관련기사 보기:NASDAQ:CNTX

1 2 3 4 5 다음 >>

Verizon Communications

Health Care Select Sector

Energy Select Sector SPDR

US Dollar vs Sterling

BNP Paribas (QX)

US Dollar vs Yen

Financial Select Sector

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관